Jump to content

TilehurstResearch

Member
  • Posts

    209
  • Joined

  • Last visited

Everything posted by TilehurstResearch

  1. In reply to: The_Muns on Friday 21/01/05 11:07am Monday a.m. could see DEG rebound quite sharply to at least the 42c placement level. Remember, 2nd qtr report due out within 4 working days !! You could be right on the money with your call Muns - "And not too long now for gold to start heading North again". [it was hours, not days or weeks ] See below... +++++DJ NY Precious Metals Review: Sharply Up On Soft Dollar Friday, January 21, 2005 7:21:22 PM http://www.osterdowjones.com/ DJ NY Precious Metals Review: Sharply Up On Soft Dollar BEND, Ore. (Dow Jones)--Fund buying sent gold and silver futures sharply higher in New York trading Friday. The main catalyst, traders said, was the correction lower in the U.S. dollar after it previously had reached its most muscular level in two months against the euro just Thursday. Buy stops were hit in both gold and silver. Overall, however, the volume was described as not particularly heavy. February gold finished $4.30 higher at $426.90, peaking at $428.50. April gold settled up $4.30 to $429, hitting a high of $430.60. Both contracts hit their most muscular levels since Jan. 5. "It's all fund buying and currency related," said Leonard Kaplan, president of Prospector Asset Management. Buy stops were hit in the February gold above the area from $425 to $426, said Kaplan. More are thought to lie in the area from $428.50 to $429. As the last of the metals markets was closing, the euro was trading at $1.3053, well up from Thursday's two-month low of $1.2923. The dollar index was down 0.57 point to 83.27. Forex-market analysts say the U.S. currency sagged by a purge of expectations that the Federal Reserve might hike interest rates more aggressively than the 25-basis-point increments that have been occurring. The U.S. economic data Friday morning contributed to this mood. The University of Michigan consumer-sentiment index fell to 95.8 from 97.1 at the end of December. March silver jumped 25.4 cents to $6.812. Buy stops have also been hit in this metal, although they were light, traders said. "Trading volumes today were not heavy," said Kaplan. A trader pointed out that the March futures moved above their 200-day moving average of $6.703. Also, he noted, the market took out resistance at the Jan. 13 and 14 highs of $6.775. The contract peaked at $6.83. March silver is in a band of resistance from $6.80 to $6.85, said Kaplan. Another trader, while agreeing that the dollar was helping gold and silver, suggested commodities as a whole were finding good demand, anyway. "Commodities as a rule are rallying fairly aggressively, whether it's oil, copper, aluminum or zinc," he said. "Across the board, commodities are gaining a lot of strength and for no particular reason." The metals have been trading "tick for tick" with the dollar for a couple of months. Yet, prices are strong considering the dollar is not terribly far from its recent highs, he said. "They (gold and silver) are very much driving themselves, as there is fairly decent fund buying and short covering going on." April platinum settled up $5.60 to $869.30, while March palladium gained $4.90 to $192.05. Activity was described as light. "The weakening dollar is it," said one trader about the main impetus. "The euro is back above $1.30." Otherwise, sources said, there were no fresh fundamental factors to drive the price action. "There was fund buying overnight in Tokyo," said one trader. One contact said it did not appear that any buy stops were triggered in the New York trade. Nearby resistance for April platinum was listed in the area from $872 to $873, after the metal hit a high of $872.90 on Wednesday that was its strongest level of the year so far. The contract peaked at $869.80. Support has been pegged around $860, as the market has bottomed here each of the last three trading days - at $860 exactly Friday morning, $860.50 on Thursday and $859.50 on Wednesday. +++++++++
  2. BUY IN GLOOM - SELL IN BOOM DEG will be announcing their 2nd qtr results shortly [have to by the end of January] and I expect some fairly impressve figures. In addition they have already announced an aggressive exploration program for 2005. With the placement at 42c (+ 1 free option) and only 90 mill shares on issue, I don't expect DEG to stay under 40c for long. Great buying opportunity if you believe the long term trend for gold is up, way up, and being pulled back only by the short term strength of the USD. Soon the focus will be back on the USA deficit and we have the elections in Irag as a potential catalyst to turn gold back to an upward trend on increased terrorist activity. DYOR and look at the top 10 shareholders. My favourite gold stock for 2005. [i now hold DEG]
  3. TilehurstResearch

    FYI

    Just to clarify what I had posted previously; I did not say the "American Connection" would be in the next announcement from SBP. I was disappointed that no announcement was made on Friday as my source was quietly confident and is in the top 10 shareholders! No dramas though. The longer it takes to put together the more informed the market will be. A simple '2nd qtr test entities commitment report' would be a real strain on the share price so I certainly hope we get more than that!! I cannot say anything about the American Connection and have been chastised for mentioning it in the first place on a public forum. All will become clear in the fullness of time....and that's one thing SBP is running out of if they want to keep some of their large core shareholders.
  4. TilehurstResearch: ADL, BQT, DEG, QRS, SBP.
  5. TilehurstResearch

    FYI

    I'll stand by what I said in my post on Monday 10th. Funding ? Wait for "The American Connection". DYOR. Fridays are good days for several reasons: last day of the working week for most + ..... avagoodweekend. hehe
  6. In reply to: sneezy on Thursday 09/12/04 10:34pm Best value future producer out there. Placement at 42c so expect a jump when confidence in gold price returning to its bull trend very soon. Great buying. Check out their chart and their announcements. I have buy order in.
  7. TilehurstResearch

    FYI

    In reply to: lyndon_webster on Monday 10/01/05 02:00pm Fear not Solbecians. Our patience will be rewarded by the brave patients. The announcement we want needs to be more than just PH1/2a results. The data is continually being updated; it's just a matter of saying "print now". However, IMHO the Board of SBP will be incorporating far more information than just the basic results. SC is miffed with the share price spikes being followed by a sell off back to square one [last conversation with him]. The next announcement needs to give the market enough information to see a re-rating of SBP and to underpin the SP at much higher levels. I'm more than happy to wait for the quality announcement.
  8. In reply to: brisvegas on Tuesday 04/01/05 10:16pm Bris - I overlooked the first chart with the 100 day MA. Cheers for that one. Looks to be at $425.50 that it rebounded from twice 2 nights ago. Watching with interest as the nervous nellies back off. thanks mate.
  9. Many thanks bris. Also have futures broker in Perth puting a detailed gold chart together for me. I'll let you know any key points he highlights. It will include 100 day moving average - my entry point on the long side. cheers briso TR
  10. Can anyone tell me the 100 day simple moving average for Gold ? Can't access my normal source. Gold has bounced from a low of USD$426 twice tonight. A break below USD$425 could see it drop to support at the 100 day simple moving average. Thanks in advance TRIG
  11. TilehurstResearch

    FYI

    Keep an eye on the BIOTECH WATCHthread on SS as well.
  12. I suggest any Biotech followers keep a close eye on SBP [solbec Pharmaceuticals] as they are expected to announce their PH 1/11a results very soon. Trial has just been completed to the stage required for FDA approval for ODS, IND, and PH 2, but as the patients on the trial are wanting to contnue with the treatment [solid tumour cancers, mesotheloima+] they are taking the opportunity to gather further evidence and data on how their lead compound Coramsine also triggers the patient's immune system to attack the cancerous cells. Also close to end of Psoriasis PH1 trials in Adelaide. Could lead to a quick commercialization being a topical cream rather than an oral or injectible treatment regime. Do your own research - or a faster way is to check the SBP thread on SS. Looking for a big 2005 from this one.
  13. TilehurstResearch

    FYI

    In reply to: AtMarket on Friday 31/12/04 12:41pm AM, Helps explain lack of sellers and volume available at around current price [within 1-1.5c] and the substantiial number of buyers and volume on the buy side [within 1-1.5c]. A re-rating by the market is long overdue and positive/outstanding PH 1 results should be the catalyst that sees the institutions get involved at last. They have naturally been cautious and need such results to meet their risk criteria before investing in any Biotech Company. Expect some key players to make a move very soon. Expect 2005 to be a great year for we patient Solbecians. Happy New Year to all SS members
  14. TilehurstResearch

    FYI

    In reply to: poorpunter on Friday 24/12/04 07:29am The Muns I know aint no lawyer but he did spend 40 days and 40 nights without food or water working on his Yule Wish to you all. No wonder he looks a tad poorly in his photo. To all Solbecians "merry bluddy xmas" and wow is 2005 gonna be big.
  15. TilehurstResearch

    FYI

    In reply to: AtMarket on Monday 20/12/04 01:24pm AM. Here's the answers to your questions: Q1 No the Phase 2 study is totally separate from this Q2 the P1 study will not be repeated but a new P1/2 study will be carried out in addition to the work already done. This will in no way effect the progress of the current program it is entirely separate.Thanks, Steve Stephen Carter Managing Director and Chief Executive Officer Solbec Pharmaceuticals Ltd.
  16. TilehurstResearch

    FYI

    In reply to: AtMarket on Monday 20/12/04 01:24pm AM - I've forwarded your valid questions to Steve Carter. Will post reply when received. I think he's back in the States again at the moment.
  17. TilehurstResearch

    FYI

    In reply to: poorpunter on Friday 17/12/04 08:12am Hi PP. The basic fact re MARF is that Chris Hahn[MARF] and Steve Carter[sBP] have now established a strong working relationship that started nearly 2 years ago. If you go back through the SBP thread, you will find some interesting comments from MARF members. These are the "mums and dads" I was referring too. They have a personal interest in SBP's Coramsine - it might just save their life or the life of a family member or friend. Remember there are about 10 yanks to 1 Aussie in the world. Forget the "not for profit research" criteria. If SBP continue to produce the results we all hope for, MARF will be supporting areas of SBP's research. In essence, if they didn't, they would be turning their back on what they came into existence for. Have a good read at www.marf.com. I have shared emails with Chris Hahn for nearly 18 months now. His key point to me in the early stages was; "they needed independent data and research analysis" i.e. not just announcements from SBP. This information is now becoming available via the PH1/11A trials, the University of WA, and Sir Charles Gairdner Hospital. Let's just say MARF are very aware of SBP's current activities.
  18. TilehurstResearch

    ADL

    In reply to: TilehurstResearch on Wednesday 15/12/04 08:40pm Some interesting links below on ADL, particularly regarding their option position to buy up to 5 mill shares in Swiss based Temenex, a leading SW provider to the banking industry. Has anyone else had a look at ADL [Admerex] in the past ? "The Speculator" in' The Bulletin' didn't purchase ADL for his public portfolio [as I thought from the October issue], but does own shares in ADL either personally or through family investments. Initial research as follows: ASX: ADL - Admerex This Company has turned around from a disastrous 2002 [same for TEMN] and with their investment in Temenex [sWX:TEMN} as detailed in the Sanford link below, it appears that their fortunes are in the hands of the performance of Temenex. TEMN chart link below looks quite promising. The clients for their banking SW include ING worldwide and other major banks worldwide. Do your own research, but IMHO, ADL should return a great profit over the next 12 months. www.temenex.com has more details. Switzerland stock exchange: www.swx.com TEMENOS http://www.swx.com/market/shares/quotes/sw...e_chart_en.html http://www.sanford.com.au/ComNews/20041215/00486193.pdf
  19. TilehurstResearch

    FYI

    In reply to: AtMarket on Friday 17/12/04 07:09am AM - the last time I spoke to Steve he mentioned that the USA had a greater understanding of SBP than here in Oz!! Remember Techvest where he presented to 1000's of institutions and then the MARF mesothelioma symposium. These 1000's of mum and dad investors will be buying as well. I would be very confident that the final choice of manufacturer in the States will want a slice of the action as well. This will help drive up the price as less and less shares will be available in Oz to buy. Expect annoncement soon on Aus Govt research fund allocation PLUS a sizable allocation of funds from MARF as they are now very keen on the SBP technology. All in all, a great announcement to hear ADR listing is going ahead.
  20. TilehurstResearch

    FYI

    'Trading stock' will be what's listed on the ASX. Expect a great move in the SP as the yanks buy what will be to them such cheap shares in a biopharm stock with great prospects. This has been on the cards for a while but the timing was delayed by the delays to PH1/11a trials. 2005 will be a great year for us holders.............marvellous !! Expect PH1/11a trial results very soon. If you look at SBP announcements over the last 6 months you can see the jigsaw taking shape. SBP have done all of this very well IMHO.
  21. TilehurstResearch

    ADL

    In reply to: topic-starter on Thursday 27/05/04 11:50am Well, this has been a hot topic hasn't it -not! Suggest some of you read their recent announcements. ADL has been reborn and looking like getting very active. Excellent write-up in the October edition of "The Bulletin". The "speculator" bought in then. Do your own research but at 15-16c seems a good entry point. I've noticed in the past that the "speculator" in "The "bulletin" is usually a month or more ahead of the action [e.g. MAL also mentioned in October edition and had a great run this week]. For what it's worth - I've taken a position in ADL with a 3 - 6 month timeframe for the market to pick up on this one.
  22. TilehurstResearch

    FYI

    In reply to: IVY on Sunday 12/12/04 09:07pm IVY - I really enjoy reading your posts as they are very informative and well researched. I especially want to thank you for the summary of the AGM - the first one I've missed since SBP was born out of Brttania Gold. You get my vote as the best informed Solbecian out there. Keep it up, and again - a big thank you. TRIG p.s. How's Karren?
  23. TilehurstResearch

    FYI

    HOW apache123 and Muns. Copy of something I sent to a fellow Solbecian. """ Oh for a bucket full of $1000 notes 2 days ago......MMMmmmmm mmm mmm m Remember I said the other evening that I was looking at ADL and MAL ? Check the move by MAL today in a sad market !!! bugger MAL MATILDA FPO 45.5 +7.5 +19.7% 44.5 45.5 39 48 39 50 406,552 ADL was up 5% as well. Watch SMN [structural monitoring...], that's on my watch page and traded at my "buy" price of 20c today, go off in the morning. Late announcement re deal with Boeing. SBP::: Looks ready to move forward with some strength IMHO as the volumes have stayed above the previous level [b4 the spike]. Also, if you look at the "real" market [in this case I do the top 5 and top 3 levels of both buyers and sellers] to see what the action is. The prices are in the minimum 0.5c increments(applies when price 10c>) with no gaps which makes this exercise even more relevant. Buyers Number Quantity Price Top 5 number Qty 2 150,000 15.5 Buyers 30 1,703,034 9 562,954 15 Sellers 18 1,042,303 -700,000 ## 9 570,080 14.5 6 243,500 14 4 176,500 13.5 Sellers Price Quantity Number Top 3 number Qty 16 97,770 3 Buyers 20 1,283,034 16.5 79,564 3 Sellers 9 300,203 -982,8318 ## 17 122,869 3 17.5 109,500 3 18 632,600 6 Compare this exercise with the total buyers and sellers........ 52 buyers for 2,896,534 shares 133 sellers with 4,990,476 shares
  24. TilehurstResearch

    FYI

    In reply to: TilehurstResearch on Thursday 02/12/04 08:43pm Good early volumes. Seems buyers are 'bottom picking'. Hopefully seen last of retracement and looking to upward move to start in the next 7 days.
  25. TilehurstResearch

    FYI

    In reply to: poorpunter on Thursday 02/12/04 11:14am To PP and Keith. Another 'option' with the options is to sell them on market and buy the shares on market. i.e. 16.5c less 3.5c = 13c. Now that's a far better entry price than forgoing any value the options have and paying 20c. Means they end up costing you 23.5c at current prices. I'm still holding my options for leverage on the various announcements due in the next 6 months; and there will be plenty more to follow.
×
×
  • Create New...